Association of Serum Fibrinogen with Hemoglobin A1c among Type 2 Diabetics patients and non-diabetics

被引:0
作者
Ashraf, Humaira [1 ]
Rani, Keenjher [2 ]
Bai, Kavita [3 ]
Bhatti, Urooj [2 ]
Rustam, Muhammad [4 ]
机构
[1] NICVD Karachi, Dept Pathol, Karachi, Pakistan
[2] LUMHS, Dept Physiol, Jamshoro, Pakistan
[3] Ind Med Coll TM Khan, Dept Physiol, Tando Muhammad Khan, Pakistan
[4] NICVD Karachi, Microbiol, Karachi, Pakistan
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2021年 / 15卷 / 01期
关键词
Fibrinogen; hemoglobin A1c; type 2 diabetes mellitus; PLASMA-FIBRINOGEN; VASCULAR COMPLICATIONS; DISEASE; MELLITUS; LEVEL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To detect the plasma fibrinogen levels in type 2 diabetes mellitus patients by taking non-diabetes healthy individuals as control and correlation between plasma fibrinogen levels and glycemic status. Methods: This case control study was conducted at department of Pathology NICVD Karachi, from November 2018 to November 2019. Diagnosed cases of type 2 DM of >18 years of age and irrespective of gender were included in the study and non-diabetic healthy individuals were taken as control. All the study subjects were assessed regarding glucose level, HbA1c level and Fibrinogen measurement. Data was collected via study proforma and analysis was done by using SPSS version 20. Results: Mean of fibrinogen level was 331.48 +/- 63.5 among diabetes group and mean fibrinogen level was 246.19 +/- 18.2 in non-diabetes group (p=<0.01). Average of hemoglobin A1c among type 2 diabetes cases and in non-diabetes cases was found to be 9.40 +/- 1.1 and 6.12 +/- 0.5 respectively (p=<0.01). Mean fibrinogen level was significantly associated with elevated glycemic status (p=<0.01). Average systolic blood pressure and diastolic blood pressure were also high among those who had Glycemic status (Hba1c) >8% (p=<0.01). Conclusion: There was significant positive association of fibrinogen with glycemic status in type 2 DM patients.
引用
收藏
页码:641 / 643
页数:3
相关论文
共 18 条
  • [1] Diabetes Prevalence Survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan
    Aamir, Azizul Hasan
    Ul-Haq, Zia
    Mahar, Saeed A.
    Qureshi, Faisal Masood
    Ahmad, Ibrar
    Jawa, Ali
    Sheikh, Aisha
    Raza, Abbas
    Fazid, Sheraz
    Jadoon, Zahid
    Ishtiaq, Osama
    Safdar, Nauman
    Afridi, Hussain
    Heald, Adrian H.
    [J]. BMJ OPEN, 2019, 9 (02):
  • [2] Prevalence of diabetic micro vascular complications at a tertiary care unit of Karachi, Pakistan
    Abro, Mujeeb
    Bin Zafar, Awn
    Fawwad, Asher
    Mustafa, Nida
    Tahir, Bilal
    Riaz, Musarrat
    Basit, Abdul
    [J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2019, 39 (02) : 325 - 330
  • [3] Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: Correlation with plasma glucagon concentrations
    Barazzoni, R
    Zanetti, M
    Davanzo, G
    Kiwanuka, E
    Carraro, P
    Tiengo, A
    Tessari, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) : 3121 - 3125
  • [4] A Study of Plasma Fibrinogen Level in Type-2 Diabetes Mellitus and its Relation to Glycemic Control
    Bembde, Archana Sachin
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2012, 28 (02) : 105 - 108
  • [5] IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
    Cho, N. H.
    Shaw, J. E.
    Karuranga, S.
    Huang, Y.
    Fernandes, J. D. da Rocha
    Ohlrogge, A. W.
    Malanda, B.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 138 : 271 - 281
  • [6] High fibrinogen level is an independent predictor of presence and extent of coronary artery disease among Italian population
    De Luca, Giuseppe
    Verdoia, Monica
    Cassetti, Ettore
    Schaffer, Alon
    Cavallino, Chiara
    Bolzani, Virginia
    Marino, Paolo
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (04) : 458 - 463
  • [7] Evaluation of plasma fibrinogen levels in type 2 diabetes mellitus
    Desai, K. N. Pannag
    Roopakala, M. S.
    Silvia, C. R. Wilma Delphine
    Kumar, K. M. Prasanna
    [J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2012, 32 (04) : 209 - 213
  • [8] Elevated fibrinogen levels and subsequent subclinical atherosclerosis: The CARDIA Study
    Green, David
    Foiles, Nancy
    Chan, Cheeling
    Schreinere, Pamela J.
    Liu, Kiang
    [J]. ATHEROSCLEROSIS, 2009, 202 (02) : 623 - 631
  • [9] C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
    Kaptoge, Stephen
    Di Angelantonio, Emanuele
    Pennells, Lisa
    Wood, Angela M.
    White, Ian R.
    Gao, Pei
    Walker, Matthew
    Thompson, Alexander
    Sarwar, Nadeem
    Caslake, Muriel
    Butterworth, Adam S.
    Amouyel, Philippe
    Assmann, Gerd
    Bakker, Stephan J. L.
    Barr, Elizabeth L. M.
    Barrett-Connor, Elizabeth
    Benjamin, Emelia J.
    Bjorkelund, Cecilia
    Brenner, Hermann
    Brunner, Eric
    Clarke, Robert
    Cooper, Jackie A.
    Cremer, Peter
    Cushman, Mary
    Dagenais, Gilles R.
    D'Agostino, Ralph B., Sr.
    Dankner, Rachel
    Davey-Smith, George
    Deeg, Dorly
    Dekker, Jacqueline M.
    Engstrom, Gunnar
    Folsom, Aaron R.
    Fowkes, F. Gerry R.
    Gallacher, John
    Gaziano, J. Michael
    Giampaoli, Simona
    Gillum, Richard F.
    Hofman, Albert
    Howard, Barbara V.
    Ingelsson, Erik
    Iso, Hiroyasu
    Jorgensen, Torben
    Kiechl, Stefan
    Kitamura, Akihiko
    Kiyohara, Yutaka
    Koenig, Wolfgang
    Kromhout, Daan
    Kuller, Lewis H.
    Lawlor, Debbie A.
    Meade, Tom W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (14) : 1310 - 1320
  • [10] Lindarto D, 2018, ASS FIBRINOGEN HBA1C